Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies

Methimazole (MMI) and propylthiouracil (PTU) are widely used antithyroid drugs (ATD) that have been approved for the treatment of hyperthyroidism. Hepatotoxicity may be induced by these drugs, though they exert dissimilar incidence rates of hepatotoxicity and, possibly, with different underlying pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Peralta, Fernando, Velasco-Martínez, Pablo, Abreu, Cristina, Cepeda, María, Fernández-Puente, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
Unusual Effects of Medical Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763277/
https://www.ncbi.nlm.nih.gov/pubmed/29340156
http://dx.doi.org/10.1530/EDM-17-0173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763277/
https://www.ncbi.nlm.nih.gov/pubmed/29340156
http://dx.doi.org/10.1530/EDM-17-0173

Ejemplares similares